Pharmacokinetics in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 15, 2024
July 29, 2024
92993772-2585-439d-bdb7-533bf4d9790e
Related Documents
Physiologically Based Pharmacokinetic Analyses — Format and Content Guidance for Industry
Guidance DocumentSeptember 4, 2018Center for Drug Evaluation and Research
Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study Design, Data Analysis, and Clinical Implications Guidance for Industry: Guidance for Industry
Guidance DocumentMarch 10, 2023Center for Drug Evaluation and Research
Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations
Guidance DocumentJune 23, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox